UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma

Annals of oncology, 2013-12, Vol.24 (12), p.3128-3135

2013

Volltextzugriff (PDF)

Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non–Small-Cell Lung Cancer

JNCI : Journal of the National Cancer Institute, 2007-03, Vol.99 (6), p.442-450

2007

Volltextzugriff (PDF)

A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer

Annals of oncology, 2012-01, Vol.23 (1), p.72-77

2012

Volltextzugriff (PDF)

EGFR and KRAS mutations as criteria for treatment with tyrosine kinase inhibitors: retro- and prospective observations in non-small-cell lung cancer

Annals of oncology, 2007-01, Vol.18 (1), p.99-103

2007

Volltextzugriff (PDF)

An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma

British journal of cancer, 2014-01, Vol.110 (2), p.510-519

2014

Volltextzugriff (PDF)

Tolerability of gefitinib in patients receiving treatment in everyday clinical practice

British journal of cancer, 2003-12, Vol.89 (S2), p.S9-S14

van Zandwijk, N

2003

Volltextzugriff (PDF)

Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales

British journal of cancer, 2014-10, Vol.111 (9), p.1860-1869

2014

Volltextzugriff (PDF)

Gemcitabine and Cisplatin as Induction Regimen for Patients With Biopsy-Proven Stage IIIA N2 Non–Small-Cell Lung Cancer: A Phase II Study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955)

Journal of clinical oncology, 2000-07, Vol.18 (14), p.2658-2664

2000

Volltextzugriff (PDF)

Differential Diagnosis of Pulmonary Carcinoma Following Head and Neck Cancer by Genetic Analysis

Clinical cancer research, 2009-02, Vol.15 (3), p.980-985

2009

Volltextzugriff (PDF)

EUROSCAN, a Randomized Trial of Vitamin A and N-Acetylcysteine in Patients With Head and Neck Cancer or Lung Cancer

JNCI : Journal of the National Cancer Institute, 2000-06, Vol.92 (12), p.977-986

2000

Volltextzugriff (PDF)

Docetaxel-based induction therapy prior to radiotherapy with or without docetaxel for non-small-cell lung cancer

British journal of cancer, 2006-05, Vol.94 (10), p.1375-1382

2006

Volltextzugriff (PDF)

An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma

British journal of cancer, 2018-03, Vol.118 (6), p.e13-e13

2018

Volltextzugriff (PDF)

Photodynamic therapy: a promising new modality for the treatment of cancer

Journal of Photochemistry & Photobiology, B: Biology, 1996-06, Vol.34 (1), p.3-12

1996

Volltextzugriff (PDF)

Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes

Lung cancer (Amsterdam, Netherlands), 2005, Vol.47 (1), p.69-80

2005

Volltextzugriff (PDF)

Comment on 'Existing prognostic models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma'

British journal of cancer, 2014-12, Vol.111 (12), p.2376-2376

2014

Volltextzugriff (PDF)

clairvoyance or reliable prediction of the future?

Annals of oncology, 2007-03, Vol.18 (3), p.407-408

2007

Volltextzugriff (PDF)

Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel

Annals of oncology, 2004-03, Vol.15 (3), p.419-426

2004

Volltextzugriff (PDF)

MC13-0031 Tumour miR-210 expression is elevated in malignant pleural mesothelioma patients with shorter survival undergoing extrapleural pneumonectomy

European journal of cancer (1990), 2013-11, Vol.49, p.S20-S20

2013

Volltextzugriff (PDF)

Morbidity and mortality in the surgery arm of EORTC 08941 trial

The European respiratory journal, 2005-08, Vol.26 (2), p.192-197

2005

Volltextzugriff (PDF)

Differences in aromatic-DNA adduct levels between alveolar macrophages and subpopulations of white blood cells from smokers

Carcinogenesis (New York), 1998-05, Vol.19 (5), p.819-825

1998

Volltextzugriff (PDF)

Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study

Journal of clinical oncology, 1997-01, Vol.15 (1), p.285-291

1997

Volltextzugriff (PDF)

Malignant mesothelioma

Internal medicine journal, 2010-11, Vol.40 (11), p.742-750

2010

Volltextzugriff (PDF)

Gefitinib as a last treatment option for non-small-cell lung cancer: durable disease control in a subset of patients

Annals of oncology, 2004-05, Vol.15 (5), p.786-792

2004

Volltextzugriff (PDF)

Adaptive intrapatient dose escalation of cisplatin in combination with low-dose vp16 in patients with nonsmall cell lung cancer

British journal of cancer, 2003-03, Vol.88 (6), p.814-821

2003

Volltextzugriff (PDF)

Non-small cell lung carcinoma of the superior sulcus: Favourable outcomes of combined modality treatment in carefully selected patients

Lung cancer (Amsterdam, Netherlands), 2008-03, Vol.59 (3), p.385-390

2008

Volltextzugriff (PDF)

1 – 25 von 281

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(250)
Mit Volltextzugriff
(231)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(169)
Life Sciences & Biomedicine
(147)
Science & Technology
(147)
Biological And Medical Sciences
(106)
Medical Sciences
(104)
Oncology
(104)
Male
(101)
Female
(100)
Middle Aged
(94)
Aged
(83)
Adult
(81)
Lung Neoplasms - Drug Therapy
(56)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(43)
Pharmacology. Drug Treatments
(41)
Pneumology
(40)
Antineoplastic Agents
(37)
Tumors Of The Respiratory System And Mediastinum
(37)
Chemotherapy
(33)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(32)
Respiratory System
(31)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma

Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non–Small-Cell Lung Cancer

A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer

EGFR and KRAS mutations as criteria for treatment with tyrosine kinase inhibitors: retro- and prospective observations in non-small-cell lung cancer

An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma

Tolerability of gefitinib in patients receiving treatment in everyday clinical practice

Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales

Gemcitabine and Cisplatin as Induction Regimen for Patients With Biopsy-Proven Stage IIIA N2 Non–Small-Cell Lung Cancer: A Phase II Study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955)

Differential Diagnosis of Pulmonary Carcinoma Following Head and Neck Cancer by Genetic Analysis

EUROSCAN, a Randomized Trial of Vitamin A and N-Acetylcysteine in Patients With Head and Neck Cancer or Lung Cancer

Docetaxel-based induction therapy prior to radiotherapy with or without docetaxel for non-small-cell lung cancer

An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma

Photodynamic therapy: a promising new modality for the treatment of cancer

Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes

Comment on 'Existing prognostic models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma'

clairvoyance or reliable prediction of the future?

Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel

MC13-0031 Tumour miR-210 expression is elevated in malignant pleural mesothelioma patients with shorter survival undergoing extrapleural pneumonectomy

Morbidity and mortality in the surgery arm of EORTC 08941 trial

Differences in aromatic-DNA adduct levels between alveolar macrophages and subpopulations of white blood cells from smokers

Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study

Malignant mesothelioma

Gefitinib as a last treatment option for non-small-cell lung cancer: durable disease control in a subset of patients

Adaptive intrapatient dose escalation of cisplatin in combination with low-dose vp16 in patients with nonsmall cell lung cancer

Non-small cell lung carcinoma of the superior sulcus: Favourable outcomes of combined modality treatment in carefully selected patients

Suchergebnisse filtern